Search
Now showing items 1-4 of 4
Long-Term Experience Providing Antiretroviral Drugs in a Fee-for-Service HIV Clinic in Uganda
(Wolters Kluwer Health, Inc., 2005-04-15)
Objective:
To describe the long-term experience of providing anti-retroviral (ARV) therapy, including CD4+ cell count and virologic response, at St. Francis Hospital, Nsambya, Uganda.
Methods:
The HIV clinic established ...
Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
(Massachusetts Medical Society., 2014-07-17)
Background
The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus ...
Development of Phenotypic and Genotypic Resistance to Antiretroviral Therapy in the UNAIDS HIV Drug Access Initiative – Uganda
(Wolters Kluwer Health, Inc., 2003-07)
Objective: We describe phenotypic drug resistance, response to therapy, and geno-typic mutations among HIV-infected patients in Uganda taking antiretroviral medica-tions for ≥ 90 days who had a viral load ≥ 1000 ...
Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa
(Wolters Kluwer Health, Inc., 2016-04-15)
Objective: To assess neurocognitive function at the first-line antiretroviral therapy failure and change on the second-line therapy.
Design: Randomized controlled trial was conducted in 5 sub-Saharan African countries.
Methods: ...